| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1.2B | $1.1B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.5B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B |
| EPS (Basic) | $1.18 | $1.08 | $1.01 | $0.72 | $0.42 | $0.28 | $0.08 | $0.06 |
| EPS (Diluted) | $1.18 | $1.08 | $1.01 | $0.71 | $0.41 | $0.28 | $0.08 | $0.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $13.4B | $12.7B | $12.2B | $11.0B | $9.6B | $9.1B | $9.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $5.5B | $5.5B | $5.0B | $5.0B | $4.2B | $3.1B | $3.1B | $3.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.0B | $7.2B | $7.0B | $6.5B | $6.1B | $5.8B | $5.3B | $5.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.8B | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.3B | $-0.8B | $-0.7B | $-1.4B | $-1.7B | $-0.6B | $-0.4B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $0.1B | $-0.0B | $0.8B | $1.1B | $0.3B | $-0.1B | $0.3B |